English

H-CYTE, INC.

EDGAR

HCYT Quarterly report (10-Q) · filed 2023-11-15

79 filing records in this dataset, filed from 2014-09-08 to 2023-11-15. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2022 Q4 · USD

Exact inputs and evidence

Revenue: 453460 USD Source
Revenue: 453460 USD Source

Operating cash flow

-91.7 thousand USD

2022 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -1913738 USD Source
Operating Cash Flow: -1822004 USD Source

Cash and cash equivalents: 544 thousand USD 2023-09-30 Source
Exact value

544000 USD
Long-term debt including current maturities: 170 thousand USD 2016-12-31 Source
Exact value

170000 USD
Shares outstanding: 712 thousand shares 2023-09-30 Source
Exact value

712170 shares

Reported share-count change

49.11% · 235 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

477610 shares · 2022-09-30· Source
712170 shares · 2023-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

453 thousand USD

2022-01-01 – 2022-12-31

Exact inputs and evidence

Revenue: 379560 USD · 2022-01-01 – 2022-03-31 Source
Revenue: 73900 USD · 2022-04-01 – 2022-06-30 Source
Revenue: 453460 USD · 2022-01-01 – 2022-09-30 Source
Revenue: 453460 USD · 2022-01-01 – 2022-06-30 Source
Revenue: 453460 USD · 2022-01-01 – 2022-12-31 Source
Revenue: 453460 USD · 2022-01-01 – 2022-09-30 Source

Net income

-3.26 million USD

2022-10-01 – 2023-09-30

Exact inputs and evidence

Net income: -10300000 USD · 2022-01-01 – 2022-12-31 Source
Net income: -8806492 USD · 2022-01-01 – 2022-09-30 Source
Net income: -2090120 USD · 2023-01-01 – 2023-03-31 Source
Net income: 820000 USD · 2023-04-01 – 2023-06-30 Source
Net income: -496000 USD · 2023-07-01 – 2023-09-30 Source

Operating cash flow

-918 thousand USD

2022-10-01 – 2023-09-30

Exact inputs and evidence

Operating cash flow: -1913738 USD · 2022-01-01 – 2022-12-31 Source
Operating cash flow: -1822004 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: -361993 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: -500393 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: -361993 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: -826371 USD · 2023-01-01 – 2023-09-30 Source
Operating cash flow: -500393 USD · 2023-01-01 – 2023-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2023-11-15.

Financial data available through: 2022-12-31.

Coverage by financial measure

Revenue: 8 of 11 periods available· newest 2022-12-31
Operating income: 9 of 11 periods available· newest 2022-12-31
Net income: 9 of 11 periods available· newest 2022-12-31
Operating cash flow: 9 of 11 periods available· newest 2022-12-31
Capital expenditure: 8 of 11 periods available· newest 2021-12-31
Total assets: 8 of 11 periods available· newest 2022-12-31
Total liabilities: 8 of 11 periods available· newest 2022-12-31
Current assets: 8 of 11 periods available· newest 2022-12-31
Current liabilities: 8 of 11 periods available· newest 2022-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 2022-12-31
long term debt: No compatible figures in this window
Shares outstanding: 8 of 11 periods available· newest 2022-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-71.9%

Prior period

USD 1.61 million

2021-01-01 – 2021-12-31
Current period

USD 453,460

2022-01-01 – 2022-12-31

Exact inputs and evidence

453460 − 1611518 = -1158058 USD

1611518 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
453460 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · H-CYTE, INC. · 2022-12-31 H-CYTE, INC. (edgar:1591165) Year-over-year change in Revenue: -1158058 USD Concept: fundies:Revenue Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:39:30Z Snapshot: 40b714c1361c21cfc16cb0d0d67ee4d4d6b4393c9b6acf07121b647bef1240bd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1591165?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 453460 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000149315223016145/form10-k.htm#490864 Filing: 000149315223016145 Input fundies:Revenue: 1611518 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000149315223016145/form10-k.htm#491503 Filing: 000149315223016145
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 5.5 million

Prior period

−USD 4.8 million

2021-01-01 – 2021-12-31
Current period

−USD 10.3 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

-10300000 − -4799307 = -5500693 USD

-4799307 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
-10300000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · H-CYTE, INC. · 2022-12-31 H-CYTE, INC. (edgar:1591165) Year-over-year change in Net income: -5500693 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:39:30Z Snapshot: 40b714c1361c21cfc16cb0d0d67ee4d4d6b4393c9b6acf07121b647bef1240bd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1591165?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -10300000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000149315223016145/form10-k.htm#813014 Filing: 000149315223016145 Input fundies:NetIncome: -4799307 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000149315223016145/form10-k.htm#673531 Filing: 000149315223016145
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 2.9 million

Prior period

−USD 4.81 million

2021-01-01 – 2021-12-31
Current period

−USD 1.91 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

-1913738 − -4809810 = 2896072 USD

-4809810 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
-1913738 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · H-CYTE, INC. · 2022-12-31 H-CYTE, INC. (edgar:1591165) Year-over-year change in Operating cash flow: 2896072 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:39:30Z Snapshot: 40b714c1361c21cfc16cb0d0d67ee4d4d6b4393c9b6acf07121b647bef1240bd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1591165?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -1913738 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000149315223016145/form10-k.htm#706328 Filing: 000149315223016145 Input fundies:OperatingCashFlow: -4809810 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000149315223016145/form10-k.htm#707039 Filing: 000149315223016145
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2022 2022-01-01 – 2022-12-31

Revenue USD 453,460 100% of revenue
Cost of revenue USD 117,601 26% of revenue
Operating expenses USD 5.44 million 1,200% of revenue
Operating income −USD 5.11 million −1,126% of revenue
Tax, interest and other Derived USD 5.19 million 1,145% of revenue
Net income −USD 10.3 million −2,271% of revenue

Cash

Operating cash flow −USD 1.91 million −422% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2014 Not shown: operating income or net income is not reported.
2015 Operating loss: operating costs were 16,858% of revenue.
2017 Operating loss: operating costs were 3,023% of revenue.
2018 Operating loss: operating costs were 153% of revenue.
2019 Operating loss: operating costs were 466% of revenue.
2020 Operating loss: operating costs were 430% of revenue.
2021 Operating loss: operating costs were 428% of revenue.
2022 Operating loss: operating costs were 1,226% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2014 2014-01-01 – 2014-12-31	0	2937032 Derived	-2937032	0 Derived	-2937032	-2783543 Derived	Source 2014-01-01 – 2014-12-31: 0 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: -2937032 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: -2937032 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: -2759875 USD Inspect Operating Cash Flow Open source 2014-01-01 – 2014-12-31: 23668 USD Inspect Capital Expenditure Open source
2015 2015-01-01 – 2015-12-31	33045	5570607 Derived	-5537562	985515 Derived	-6523077	-5989002 Derived	Source 2015-01-01 – 2015-12-31: 33045 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -5537562 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -6523077 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: -5981943 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 7059 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	207344	6268283 Derived	-6060939	395538 Derived	-6456477	-5607149 Derived	Source 2017-01-01 – 2017-12-31: 207344 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -6060939 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -6456477 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -5590467 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 16682 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	7883115	12075161 Derived	-4192046	202103 Derived	-4394149	-3556002 Derived	Source 2018-01-01 – 2018-12-31: 7883115 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -4192046 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -4394149 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -3544707 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 11295 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	8346858	38905243 Derived	-30558385	-750507 Derived	-29807878	-12311961 Derived	Source 2019-01-01 – 2019-12-31: 8346858 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -30558385 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -29807878 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -12291275 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 20686 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	2150672	9243016 Derived	-7092344	-633108 Derived	-6459236	-7260027 Derived	Source 2020-01-01 – 2020-12-31: 2150672 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -7092344 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -6459236 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -7257743 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 2284 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	1611518	6897122 Derived	-5285604	-486297 Derived	-4799307	-4817640 Derived	Source 2021-01-01 – 2021-12-31: 1611518 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -5285604 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -4799307 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -4809810 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 7830 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	453460	5559233 Derived	-5105773	5194227 Derived	-10300000	Unavailable	Source 2022-01-01 – 2022-12-31: 453460 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -5105773 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -10300000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -1913738 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 453.5K 2022

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20142014-12-31	Revenue	0	Revenue: 0 Open source
20152015-12-31	Revenue	33045	Revenue: 33045 Open source
20172017-12-31	Revenue	207344	Revenue: 207344 Open source
20182018-12-31	Revenue	7883115	Revenue: 7883115 Open source
20192019-12-31	Revenue	8346858	Revenue: 8346858 Open source
20202020-12-31	Revenue	2150672	Revenue: 2150672 Open source
20212021-12-31	Revenue	1611518	Revenue: 1611518 Open source
20222022-12-31	Revenue	453460	Revenue: 453460 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-71.9% 2022

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20142014-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
20152015-12-31	Year over year	No prior comparable period	Revenue: 33045 Open source Revenue: 0 Open source
20172017-12-31	Year over year	No prior comparable period	Revenue: 207344 Open source
20182018-12-31	Year over year	3,701.9%	Revenue: 7883115 Open source Revenue: 207344 Open source
20192019-12-31	Year over year	5.9%	Revenue: 8346858 Open source Revenue: 7883115 Open source
20202020-12-31	Year over year	-74.2%	Revenue: 2150672 Open source Revenue: 8346858 Open source
20212021-12-31	Year over year	-25.1%	Revenue: 1611518 Open source Revenue: 2150672 Open source
20222022-12-31	Year over year	-71.9%	Revenue: 453460 Open source Revenue: 1611518 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -1,126% 2022

Net margin -2,271.4% 2022

Free cash flow margin -299% 2021

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20142014-12-31	Operating margin	Not reported	Operating Income: -2937032 Open source Revenue: 0 Open source
20152015-12-31	Operating margin	-16,757.6%	Operating Income: -5537562 Open source Revenue: 33045 Open source
20172017-12-31	Operating margin	-2,923.1%	Operating Income: -6060939 Open source Revenue: 207344 Open source
20182018-12-31	Operating margin	-53.2%	Operating Income: -4192046 Open source Revenue: 7883115 Open source
20192019-12-31	Operating margin	-366.1%	Operating Income: -30558385 Open source Revenue: 8346858 Open source
20202020-12-31	Operating margin	-329.8%	Operating Income: -7092344 Open source Revenue: 2150672 Open source
20212021-12-31	Operating margin	-328%	Operating Income: -5285604 Open source Revenue: 1611518 Open source
20222022-12-31	Operating margin	-1,126%	Operating Income: -5105773 Open source Revenue: 453460 Open source
20142014-12-31	Net margin	Not reported	Net Income: -2937032 Open source Revenue: 0 Open source
20152015-12-31	Net margin	-19,740%	Net Income: -6523077 Open source Revenue: 33045 Open source
20172017-12-31	Net margin	-3,113.9%	Net Income: -6456477 Open source Revenue: 207344 Open source
20182018-12-31	Net margin	-55.7%	Net Income: -4394149 Open source Revenue: 7883115 Open source
20192019-12-31	Net margin	-357.1%	Net Income: -29807878 Open source Revenue: 8346858 Open source
20202020-12-31	Net margin	-300.3%	Net Income: -6459236 Open source Revenue: 2150672 Open source
20212021-12-31	Net margin	-297.8%	Net Income: -4799307 Open source Revenue: 1611518 Open source
20222022-12-31	Net margin	-2,271.4%	Net Income: -10300000 Open source Revenue: 453460 Open source
20142014-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -2759875 Open source Capital Expenditure: 23668 Open source
20152015-12-31	Free cash flow margin	-18,123.8%	Revenue: 33045 Open source Operating Cash Flow: -5981943 Open source Capital Expenditure: 7059 Open source
20172017-12-31	Free cash flow margin	-2,704.3%	Revenue: 207344 Open source Operating Cash Flow: -5590467 Open source Capital Expenditure: 16682 Open source
20182018-12-31	Free cash flow margin	-45.1%	Revenue: 7883115 Open source Operating Cash Flow: -3544707 Open source Capital Expenditure: 11295 Open source
20192019-12-31	Free cash flow margin	-147.5%	Revenue: 8346858 Open source Operating Cash Flow: -12291275 Open source Capital Expenditure: 20686 Open source
20202020-12-31	Free cash flow margin	-337.6%	Revenue: 2150672 Open source Operating Cash Flow: -7257743 Open source Capital Expenditure: 2284 Open source
20212021-12-31	Free cash flow margin	-299%	Revenue: 1611518 Open source Operating Cash Flow: -4809810 Open source Capital Expenditure: 7830 Open source
20222022-12-31	Free cash flow margin	Not reported	Revenue: 453460 Open source Operating Cash Flow: -1913738 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -1.9M 2022

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20142014-12-31	Operating cash flow	-2759875	Operating Cash Flow: -2759875 Open source
20152015-12-31	Operating cash flow	-5981943	Operating Cash Flow: -5981943 Open source
20172017-12-31	Operating cash flow	-5590467	Operating Cash Flow: -5590467 Open source
20182018-12-31	Operating cash flow	-3544707	Operating Cash Flow: -3544707 Open source
20192019-12-31	Operating cash flow	-12291275	Operating Cash Flow: -12291275 Open source
20202020-12-31	Operating cash flow	-7257743	Operating Cash Flow: -7257743 Open source
20212021-12-31	Operating cash flow	-4809810	Operating Cash Flow: -4809810 Open source
20222022-12-31	Operating cash flow	-1913738	Operating Cash Flow: -1913738 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -4.8M 2021

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20142014-12-31	Free cash flow	-2783543	Operating Cash Flow: -2759875 Open source Capital Expenditure: 23668 Open source
20152015-12-31	Free cash flow	-5989002	Operating Cash Flow: -5981943 Open source Capital Expenditure: 7059 Open source
20172017-12-31	Free cash flow	-5607149	Operating Cash Flow: -5590467 Open source Capital Expenditure: 16682 Open source
20182018-12-31	Free cash flow	-3556002	Operating Cash Flow: -3544707 Open source Capital Expenditure: 11295 Open source
20192019-12-31	Free cash flow	-12311961	Operating Cash Flow: -12291275 Open source Capital Expenditure: 20686 Open source
20202020-12-31	Free cash flow	-7260027	Operating Cash Flow: -7257743 Open source Capital Expenditure: 2284 Open source
20212021-12-31	Free cash flow	-4817640	Operating Cash Flow: -4809810 Open source Capital Expenditure: 7830 Open source
20222022-12-31	Free cash flow	Unavailable	Operating Cash Flow: -1913738 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

6,912.5% 2022

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20142014-12-31	Liabilities / assets	5.2%	Total Liabilities: 360107 Open source Total Assets: 6865756 Open source
20152015-12-31	Liabilities / assets	13.1%	Total Liabilities: 1509009 Open source Total Assets: 11531734 Open source
20172017-12-31	Liabilities / assets	41.9%	Total Liabilities: 514732 Open source Total Assets: 1228153 Open source
20182018-12-31	Liabilities / assets	1,433.6%	Total Liabilities: 6521436 Open source Total Assets: 454896 Open source
20192019-12-31	Liabilities / assets	204%	Total Liabilities: 6670861 Open source Total Assets: 3270612 Open source
20202020-12-31	Liabilities / assets	147.5%	Total Liabilities: 3252007 Open source Total Assets: 2204168 Open source
20212021-12-31	Liabilities / assets	1,550.6%	Total Liabilities: 4983648 Open source Total Assets: 321405 Open source
20222022-12-31	Liabilities / assets	6,912.5%	Total Liabilities: 9494743 Open source Total Assets: 137357 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.01× 2022

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20142014-12-31	Current assets / current liabilities	19×	Current Assets: 6841306 Open source Current Liabilities: 360107 Open source
20152015-12-31	Current assets / current liabilities	3.01×	Current Assets: 1774929 Open source Current Liabilities: 589878 Open source
20172017-12-31	Current assets / current liabilities	2.4×	Current Assets: 1138229 Open source Current Liabilities: 475054 Open source
20182018-12-31	Current assets / current liabilities	0.07×	Current Assets: 149692 Open source Current Liabilities: 2192930 Open source
20192019-12-31	Current assets / current liabilities	0.39×	Current Assets: 2275579 Open source Current Liabilities: 5773887 Open source
20202020-12-31	Current assets / current liabilities	0.61×	Current Assets: 1757202 Open source Current Liabilities: 2892686 Open source
20212021-12-31	Current assets / current liabilities	0.04×	Current Assets: 197456 Open source Current Liabilities: 4920880 Open source
20222022-12-31	Current assets / current liabilities	0.01×	Current Assets: 83845 Open source Current Liabilities: 7476893 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2014 2014-01-01 – 2014-12-31	−USD 2.94 million Exact value Exact value: -2937032 USD 2014-01-01 – 2014-12-31: -2937032 USD Inspect Net Income Open source Share or cite Citation for Net Income · H-CYTE, INC. · 2014-12-31 H-CYTE, INC. (edgar:1591165) Net Income: -2937032 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T13:39:30Z Snapshot: 40b714c1361c21cfc16cb0d0d67ee4d4d6b4393c9b6acf07121b647bef1240bd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1591165/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2937032 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000141588916006247/mdvxu-20160331.xml#95873 Filing: 000141588916006247 The citation records this snapshot. The page link may show a newer release later.	−USD 2.76 million Exact value Exact value: -2759875 USD 2014-01-01 – 2014-12-31: -2759875 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · H-CYTE, INC. · 2014-12-31 H-CYTE, INC. (edgar:1591165) Operating Cash Flow: -2759875 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T13:39:30Z Snapshot: 40b714c1361c21cfc16cb0d0d67ee4d4d6b4393c9b6acf07121b647bef1240bd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1591165/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2759875 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000141588916006247/mdvxu-20160331.xml#106630 Filing: 000141588916006247 The citation records this snapshot. The page link may show a newer release later.	USD 23,668 Exact value Exact value: 23668 USD 2014-01-01 – 2014-12-31: 23668 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · H-CYTE, INC. · 2014-12-31 H-CYTE, INC. (edgar:1591165) Capital Expenditure: 23668 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T13:39:30Z Snapshot: 40b714c1361c21cfc16cb0d0d67ee4d4d6b4393c9b6acf07121b647bef1240bd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1591165/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 23668 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000141588916006247/mdvxu-20160331.xml#111440 Filing: 000141588916006247 The citation records this snapshot. The page link may show a newer release later.	−USD 2.78 million Calculation and evidence -2759875 − 23668 USD Exact free cash flow: -2783543 USD 2014-01-01 – 2014-12-31: -2759875 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 23668 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · H-CYTE, INC. · 2014-12-31 H-CYTE, INC. (edgar:1591165) Free cash flow: -2783543 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T13:39:30Z Snapshot: 40b714c1361c21cfc16cb0d0d67ee4d4d6b4393c9b6acf07121b647bef1240bd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1591165?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2759875 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000141588916006247/mdvxu-20160331.xml#106630 Filing: 000141588916006247 Input fundies:CapitalExpenditure: 23668 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000141588916006247/mdvxu-20160331.xml#111440 Filing: 000141588916006247 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	−USD 6.52 million Exact value Exact value: -6523077 USD 2015-01-01 – 2015-12-31: -6523077 USD Inspect Net Income Open source Share or cite Citation for Net Income · H-CYTE, INC. · 2015-12-31 H-CYTE, INC. (edgar:1591165) Net Income: -6523077 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T13:39:30Z Snapshot: 40b714c1361c21cfc16cb0d0d67ee4d4d6b4393c9b6acf07121b647bef1240bd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1591165/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6523077 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000165495417002874/mdvxu-20161231.xml#63090 Filing: 000165495417002874 The citation records this snapshot. The page link may show a newer release later.	−USD 5.98 million Exact value Exact value: -5981943 USD 2015-01-01 – 2015-12-31: -5981943 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · H-CYTE, INC. · 2015-12-31 H-CYTE, INC. (edgar:1591165) Operating Cash Flow: -5981943 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T13:39:30Z Snapshot: 40b714c1361c21cfc16cb0d0d67ee4d4d6b4393c9b6acf07121b647bef1240bd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1591165/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5981943 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000165495417002874/mdvxu-20161231.xml#82581 Filing: 000165495417002874 The citation records this snapshot. The page link may show a newer release later.	USD 7,059 Exact value Exact value: 7059 USD 2015-01-01 – 2015-12-31: 7059 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · H-CYTE, INC. · 2015-12-31 H-CYTE, INC. (edgar:1591165) Capital Expenditure: 7059 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T13:39:30Z Snapshot: 40b714c1361c21cfc16cb0d0d67ee4d4d6b4393c9b6acf07121b647bef1240bd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1591165/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7059 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000165495417002874/mdvxu-20161231.xml#85293 Filing: 000165495417002874 The citation records this snapshot. The page link may show a newer release later.	−USD 5.99 million Calculation and evidence -5981943 − 7059 USD Exact free cash flow: -5989002 USD 2015-01-01 – 2015-12-31: -5981943 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 7059 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · H-CYTE, INC. · 2015-12-31 H-CYTE, INC. (edgar:1591165) Free cash flow: -5989002 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T13:39:30Z Snapshot: 40b714c1361c21cfc16cb0d0d67ee4d4d6b4393c9b6acf07121b647bef1240bd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1591165?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5981943 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000165495417002874/mdvxu-20161231.xml#82581 Filing: 000165495417002874 Input fundies:CapitalExpenditure: 7059 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000165495417002874/mdvxu-20161231.xml#85293 Filing: 000165495417002874 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	−USD 16.23 million Exact value Exact value: -16227484 USD 2016-01-01 – 2016-12-31: -16227484 USD Inspect Net Income Open source Share or cite Citation for Net Income · H-CYTE, INC. · 2016-12-31 H-CYTE, INC. (edgar:1591165) Net Income: -16227484 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T13:39:30Z Snapshot: 40b714c1361c21cfc16cb0d0d67ee4d4d6b4393c9b6acf07121b647bef1240bd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1591165/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16227484 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000149315218004286/mdvx-20171231.xml#130695 Filing: 000149315218004286 The citation records this snapshot. The page link may show a newer release later.	−USD 5.43 million Exact value Exact value: -5427468 USD 2016-01-01 – 2016-12-31: -5427468 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · H-CYTE, INC. · 2016-12-31 H-CYTE, INC. (edgar:1591165) Operating Cash Flow: -5427468 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T13:39:30Z Snapshot: 40b714c1361c21cfc16cb0d0d67ee4d4d6b4393c9b6acf07121b647bef1240bd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1591165/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5427468 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000149315218004286/mdvx-20171231.xml#138388 Filing: 000149315218004286 The citation records this snapshot. The page link may show a newer release later.	USD 85,133 Exact value Exact value: 85133 USD 2016-01-01 – 2016-12-31: 85133 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · H-CYTE, INC. · 2016-12-31 H-CYTE, INC. (edgar:1591165) Capital Expenditure: 85133 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T13:39:30Z Snapshot: 40b714c1361c21cfc16cb0d0d67ee4d4d6b4393c9b6acf07121b647bef1240bd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1591165/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 85133 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000149315218004286/mdvx-20171231.xml#138755 Filing: 000149315218004286 The citation records this snapshot. The page link may show a newer release later.	−USD 5.51 million Calculation and evidence -5427468 − 85133 USD Exact free cash flow: -5512601 USD 2016-01-01 – 2016-12-31: -5427468 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 85133 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · H-CYTE, INC. · 2016-12-31 H-CYTE, INC. (edgar:1591165) Free cash flow: -5512601 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T13:39:30Z Snapshot: 40b714c1361c21cfc16cb0d0d67ee4d4d6b4393c9b6acf07121b647bef1240bd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1591165?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5427468 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000149315218004286/mdvx-20171231.xml#138388 Filing: 000149315218004286 Input fundies:CapitalExpenditure: 85133 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000149315218004286/mdvx-20171231.xml#138755 Filing: 000149315218004286 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 6.46 million Exact value Exact value: -6456477 USD 2017-01-01 – 2017-12-31: -6456477 USD Inspect Net Income Open source Share or cite Citation for Net Income · H-CYTE, INC. · 2017-12-31 H-CYTE, INC. (edgar:1591165) Net Income: -6456477 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:39:30Z Snapshot: 40b714c1361c21cfc16cb0d0d67ee4d4d6b4393c9b6acf07121b647bef1240bd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1591165/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6456477 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000149315219005081/mdvx-20181231.xml#172318 Filing: 000149315219005081 The citation records this snapshot. The page link may show a newer release later.	−USD 5.59 million Exact value Exact value: -5590467 USD 2017-01-01 – 2017-12-31: -5590467 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · H-CYTE, INC. · 2017-12-31 H-CYTE, INC. (edgar:1591165) Operating Cash Flow: -5590467 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:39:30Z Snapshot: 40b714c1361c21cfc16cb0d0d67ee4d4d6b4393c9b6acf07121b647bef1240bd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1591165/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5590467 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000149315219005081/mdvx-20181231.xml#513872 Filing: 000149315219005081 The citation records this snapshot. The page link may show a newer release later.	USD 16,682 Exact value Exact value: 16682 USD 2017-01-01 – 2017-12-31: 16682 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · H-CYTE, INC. · 2017-12-31 H-CYTE, INC. (edgar:1591165) Capital Expenditure: 16682 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:39:30Z Snapshot: 40b714c1361c21cfc16cb0d0d67ee4d4d6b4393c9b6acf07121b647bef1240bd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1591165/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 16682 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000149315219005081/mdvx-20181231.xml#518393 Filing: 000149315219005081 The citation records this snapshot. The page link may show a newer release later.	−USD 5.61 million Calculation and evidence -5590467 − 16682 USD Exact free cash flow: -5607149 USD 2017-01-01 – 2017-12-31: -5590467 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 16682 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · H-CYTE, INC. · 2017-12-31 H-CYTE, INC. (edgar:1591165) Free cash flow: -5607149 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:39:30Z Snapshot: 40b714c1361c21cfc16cb0d0d67ee4d4d6b4393c9b6acf07121b647bef1240bd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1591165?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5590467 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000149315219005081/mdvx-20181231.xml#513872 Filing: 000149315219005081 Input fundies:CapitalExpenditure: 16682 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000149315219005081/mdvx-20181231.xml#518393 Filing: 000149315219005081 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 4.39 million Exact value Exact value: -4394149 USD 2018-01-01 – 2018-12-31: -4394149 USD Inspect Net Income Open source Share or cite Citation for Net Income · H-CYTE, INC. · 2018-12-31 H-CYTE, INC. (edgar:1591165) Net Income: -4394149 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:39:30Z Snapshot: 40b714c1361c21cfc16cb0d0d67ee4d4d6b4393c9b6acf07121b647bef1240bd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1591165/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4394149 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000149315220012424/hcyt-20200331.xml#374940 Filing: 000149315220012424 The citation records this snapshot. The page link may show a newer release later.	−USD 3.54 million Exact value Exact value: -3544707 USD 2018-01-01 – 2018-12-31: -3544707 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · H-CYTE, INC. · 2018-12-31 H-CYTE, INC. (edgar:1591165) Operating Cash Flow: -3544707 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:39:30Z Snapshot: 40b714c1361c21cfc16cb0d0d67ee4d4d6b4393c9b6acf07121b647bef1240bd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1591165/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3544707 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000149315220012424/hcyt-20200331.xml#553379 Filing: 000149315220012424 The citation records this snapshot. The page link may show a newer release later.	USD 11,295 Exact value Exact value: 11295 USD 2018-01-01 – 2018-12-31: 11295 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · H-CYTE, INC. · 2018-12-31 H-CYTE, INC. (edgar:1591165) Capital Expenditure: 11295 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:39:30Z Snapshot: 40b714c1361c21cfc16cb0d0d67ee4d4d6b4393c9b6acf07121b647bef1240bd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1591165/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 11295 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000149315220012424/hcyt-20200331.xml#873190 Filing: 000149315220012424 The citation records this snapshot. The page link may show a newer release later.	−USD 3.56 million Calculation and evidence -3544707 − 11295 USD Exact free cash flow: -3556002 USD 2018-01-01 – 2018-12-31: -3544707 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 11295 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · H-CYTE, INC. · 2018-12-31 H-CYTE, INC. (edgar:1591165) Free cash flow: -3556002 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:39:30Z Snapshot: 40b714c1361c21cfc16cb0d0d67ee4d4d6b4393c9b6acf07121b647bef1240bd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1591165?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3544707 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000149315220012424/hcyt-20200331.xml#553379 Filing: 000149315220012424 Input fundies:CapitalExpenditure: 11295 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000149315220012424/hcyt-20200331.xml#873190 Filing: 000149315220012424 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 29.81 million Exact value Exact value: -29807878 USD 2019-01-01 – 2019-12-31: -29807878 USD Inspect Net Income Open source Share or cite Citation for Net Income · H-CYTE, INC. · 2019-12-31 H-CYTE, INC. (edgar:1591165) Net Income: -29807878 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:39:30Z Snapshot: 40b714c1361c21cfc16cb0d0d67ee4d4d6b4393c9b6acf07121b647bef1240bd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1591165/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -29807878 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000149315222003330/forms-1.htm#2544740 Filing: 000149315222003330 The citation records this snapshot. The page link may show a newer release later.	−USD 12.29 million Exact value Exact value: -12291275 USD 2019-01-01 – 2019-12-31: -12291275 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · H-CYTE, INC. · 2019-12-31 H-CYTE, INC. (edgar:1591165) Operating Cash Flow: -12291275 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:39:30Z Snapshot: 40b714c1361c21cfc16cb0d0d67ee4d4d6b4393c9b6acf07121b647bef1240bd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1591165/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -12291275 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000149315222003330/forms-1.htm#2928037 Filing: 000149315222003330 The citation records this snapshot. The page link may show a newer release later.	USD 20,686 Exact value Exact value: 20686 USD 2019-01-01 – 2019-12-31: 20686 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · H-CYTE, INC. · 2019-12-31 H-CYTE, INC. (edgar:1591165) Capital Expenditure: 20686 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:39:30Z Snapshot: 40b714c1361c21cfc16cb0d0d67ee4d4d6b4393c9b6acf07121b647bef1240bd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1591165/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 20686 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000149315222003330/forms-1.htm#2931797 Filing: 000149315222003330 The citation records this snapshot. The page link may show a newer release later.	−USD 12.31 million Calculation and evidence -12291275 − 20686 USD Exact free cash flow: -12311961 USD 2019-01-01 – 2019-12-31: -12291275 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 20686 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · H-CYTE, INC. · 2019-12-31 H-CYTE, INC. (edgar:1591165) Free cash flow: -12311961 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:39:30Z Snapshot: 40b714c1361c21cfc16cb0d0d67ee4d4d6b4393c9b6acf07121b647bef1240bd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1591165?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -12291275 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000149315222003330/forms-1.htm#2928037 Filing: 000149315222003330 Input fundies:CapitalExpenditure: 20686 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000149315222003330/forms-1.htm#2931797 Filing: 000149315222003330 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 6.46 million Exact value Exact value: -6459236 USD 2020-01-01 – 2020-12-31: -6459236 USD Inspect Net Income Open source Share or cite Citation for Net Income · H-CYTE, INC. · 2020-12-31 H-CYTE, INC. (edgar:1591165) Net Income: -6459236 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:39:30Z Snapshot: 40b714c1361c21cfc16cb0d0d67ee4d4d6b4393c9b6acf07121b647bef1240bd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1591165/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6459236 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000149315222005486/form10-k.htm#545789 Filing: 000149315222005486 The citation records this snapshot. The page link may show a newer release later.	−USD 7.26 million Exact value Exact value: -7257743 USD 2020-01-01 – 2020-12-31: -7257743 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · H-CYTE, INC. · 2020-12-31 H-CYTE, INC. (edgar:1591165) Operating Cash Flow: -7257743 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:39:30Z Snapshot: 40b714c1361c21cfc16cb0d0d67ee4d4d6b4393c9b6acf07121b647bef1240bd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1591165/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7257743 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000149315222005486/form10-k.htm#615302 Filing: 000149315222005486 The citation records this snapshot. The page link may show a newer release later.	USD 2,284 Exact value Exact value: 2284 USD 2020-01-01 – 2020-12-31: 2284 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · H-CYTE, INC. · 2020-12-31 H-CYTE, INC. (edgar:1591165) Capital Expenditure: 2284 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:39:30Z Snapshot: 40b714c1361c21cfc16cb0d0d67ee4d4d6b4393c9b6acf07121b647bef1240bd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1591165/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2284 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000149315222005486/form10-k.htm#617406 Filing: 000149315222005486 The citation records this snapshot. The page link may show a newer release later.	−USD 7.26 million Calculation and evidence -7257743 − 2284 USD Exact free cash flow: -7260027 USD 2020-01-01 – 2020-12-31: -7257743 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 2284 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · H-CYTE, INC. · 2020-12-31 H-CYTE, INC. (edgar:1591165) Free cash flow: -7260027 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:39:30Z Snapshot: 40b714c1361c21cfc16cb0d0d67ee4d4d6b4393c9b6acf07121b647bef1240bd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1591165?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7257743 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000149315222005486/form10-k.htm#615302 Filing: 000149315222005486 Input fundies:CapitalExpenditure: 2284 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000149315222005486/form10-k.htm#617406 Filing: 000149315222005486 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 4.8 million Exact value Exact value: -4799307 USD 2021-01-01 – 2021-12-31: -4799307 USD Inspect Net Income Open source Share or cite Citation for Net Income · H-CYTE, INC. · 2021-12-31 H-CYTE, INC. (edgar:1591165) Net Income: -4799307 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:39:30Z Snapshot: 40b714c1361c21cfc16cb0d0d67ee4d4d6b4393c9b6acf07121b647bef1240bd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1591165/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4799307 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000149315223016145/form10-k.htm#673531 Filing: 000149315223016145 The citation records this snapshot. The page link may show a newer release later.	−USD 4.81 million Exact value Exact value: -4809810 USD 2021-01-01 – 2021-12-31: -4809810 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · H-CYTE, INC. · 2021-12-31 H-CYTE, INC. (edgar:1591165) Operating Cash Flow: -4809810 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:39:30Z Snapshot: 40b714c1361c21cfc16cb0d0d67ee4d4d6b4393c9b6acf07121b647bef1240bd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1591165/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4809810 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000149315223016145/form10-k.htm#707039 Filing: 000149315223016145 The citation records this snapshot. The page link may show a newer release later.	USD 7,830 Exact value Exact value: 7830 USD 2021-01-01 – 2021-12-31: 7830 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · H-CYTE, INC. · 2021-12-31 H-CYTE, INC. (edgar:1591165) Capital Expenditure: 7830 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:39:30Z Snapshot: 40b714c1361c21cfc16cb0d0d67ee4d4d6b4393c9b6acf07121b647bef1240bd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1591165/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7830 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000149315223016145/form10-k.htm#710499 Filing: 000149315223016145 The citation records this snapshot. The page link may show a newer release later.	−USD 4.82 million Calculation and evidence -4809810 − 7830 USD Exact free cash flow: -4817640 USD 2021-01-01 – 2021-12-31: -4809810 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 7830 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · H-CYTE, INC. · 2021-12-31 H-CYTE, INC. (edgar:1591165) Free cash flow: -4817640 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:39:30Z Snapshot: 40b714c1361c21cfc16cb0d0d67ee4d4d6b4393c9b6acf07121b647bef1240bd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1591165?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4809810 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000149315223016145/form10-k.htm#707039 Filing: 000149315223016145 Input fundies:CapitalExpenditure: 7830 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000149315223016145/form10-k.htm#710499 Filing: 000149315223016145 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 10.3 million Exact value Exact value: -10300000 USD 2022-01-01 – 2022-12-31: -10300000 USD Inspect Net Income Open source Share or cite Citation for Net Income · H-CYTE, INC. · 2022-12-31 H-CYTE, INC. (edgar:1591165) Net Income: -10300000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:39:30Z Snapshot: 40b714c1361c21cfc16cb0d0d67ee4d4d6b4393c9b6acf07121b647bef1240bd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1591165/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10300000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000149315223016145/form10-k.htm#813014 Filing: 000149315223016145 The citation records this snapshot. The page link may show a newer release later.	−USD 1.91 million Exact value Exact value: -1913738 USD 2022-01-01 – 2022-12-31: -1913738 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · H-CYTE, INC. · 2022-12-31 H-CYTE, INC. (edgar:1591165) Operating Cash Flow: -1913738 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:39:30Z Snapshot: 40b714c1361c21cfc16cb0d0d67ee4d4d6b4393c9b6acf07121b647bef1240bd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1591165/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1913738 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1591165/000149315223016145/form10-k.htm#706328 Filing: 000149315223016145 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

79 filings · 2,215 latest values · 2,215 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001591165, 1591165, HCYT, IVRN, MDVX, edgar:1591165

Also known as H-CYTE, INC, H-CYTE, INC, H-CYTE, INC, H-CYTE, INC., INNOVEREN SCIENTIFIC, INC, Innoveren Scientific, Inc., MEDOVEX CORP., Medovex Corp., SpineZ

H-CYTE, INC.

Latest quarter

Revenue

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2022 2022-01-01 – 2022-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation